Upgrade

SL Science Holding Limited

SLBT

Last
$1.51
Day
-0.7%
1y
-97.0%
5y
-97.0%
52w
-97.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
1.81
EMA 50
4.07
EMA 200
23.71
20d high
-30.3%
5y high
-97.2%
5y range
0th
Website · 14 employees · Taiwan

Positions held

Your positions

SLBT isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-12
Hold
avoid
Signal
Sell
Target
$1.77
Stop
$1.31
Stop distance
13.3%
Target vs last
+17.2%

Bull / bear case

Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.

Bull case
  • SL Science Holding Limited operates in the biotechnology sector, which is characterized by rapid innovation and significant growth potential, especially as healthcare needs evolve.
  • In 2023, SLBT achieved a gross margin of 83.96%, indicating strong profitability on its products despite overall challenges.
  • The company's current ratio stands at 4.899, suggesting a strong liquidity position to cover short-term liabilities.
Bear case
  • The company has a high debt-to-equity ratio of 6.462, which raises concerns about financial stability and the ability to manage debt.
  • SLBT reported a revenue decline of 7.6% year-over-year, reflecting challenges in maintaining sales growth.
  • The overall score for SLBT is a 'Sell' with a score of -12.00, indicating negative market sentiment and a bearish outlook.

Fundamentals

Market cap$852.35MEnterprise value$2.52MTrailing P/E—Forward P/E—
PEG—Price / book1.18Beta—Dividend yield0.00%
Revenue growth-7.6%Earnings growth—Gross margin38.4%Operating margin-142.6%
Profit margin-72.5%ROE—ROA—Debt / equity0.06
Current ratio4.90Free cash flow—Analyst recommendationnoneMean target—
52w high$14.5052w low$1.42
SLBT · daily-9.5% over 13 sessions
Close EMA21 EMA50 EMA200
1.391.541.701.852.002026-092026-092026-092026-092026-102026-102026-10